Search - tctmd.com

Displaying 61 - 80 of 241

Sort: Relevancy | Date

News Daily News

The Hunt for Protein Culprits in COVID-19’s Cardiac Complications

Michael O'Riordan

May 06, 2022

Seasonal, but No Year-round, Protection With Flu Shots in HF: IVVE

News Conference News ACC 2022

Seasonal, but No Year-round Help for HF With Flu Shots: IVVE

Yael L. Maxwell

April 03, 2022

News Conference News ACC 2022

What’s Going to Be Hot at ACC 2022, In Person or Virtual

Shelley Wood

March 28, 2022

News Daily News

FDA Grants Expanded Indication to CardioMEMS PA Pressure Monitor

Shelley Wood

February 22, 2022

News Daily News

Study Touts Benefits of Exercise as Primary CVD Prevention in Older Adults

L.A. McKeown

February 15, 2022

News Features

Reports of Sudden Deaths Among Athletes After COVID-19 Vax Are ‘Misinformation’

Todd Neale

February 14, 2022

News Conference News THT 2022

Xenotransplant of Pig Heart ‘Just Baby Steps,’ Lead Surgeon Says

Yael L. Maxwell

February 07, 2022

News Opinion CV Team Dispatch

February 2022 News Roundup

L.A. McKeown

February 01, 2022

News Features

Realistic Expectations Emerge After Initial Excitement Over Xenotransplant

Yael L. Maxwell

January 21, 2022

News Daily News

Cardiac Abnormalities Seen After COVID-19, but Recovery Is Quick

Michael O'Riordan

January 20, 2022

News Opinion CV Team Dispatch

January 2022 News Roundup

L.A. McKeown

January 01, 2022

News Features

World-wise: As In-Person Meetings Resume, Global Voices Hope to Be Heard

Shelley Wood

December 13, 2021

News Daily News

Meta-analysis of Pivotal SGLT2 Inhibitor Trials Boosts Hopes in HFpEF

L.A. McKeown

December 07, 2021

News Conference News AHA 2021

Risk-Based EHR Alert Doesn’t Improve HF Care or Outcomes: REVEAL-HF

Michael O'Riordan

November 19, 2021

News Conference News AHA 2021

Empagliflozin Retains Benefits in ‘True’ HFpEF Patients

Todd Neale

November 17, 2021

News Conference News

Trial of Cell Therapy for HF Misses Primary Endpoint, but Signals a Path Forward

Todd Neale

November 16, 2021

News Conference News AHA 2021

Canagliflozin Improves Quality of Life in HF Patients

Michael O'Riordan

November 16, 2021

News Conference News AHA 2021

Empagliflozin Safe in Acute HF, Improves ‘Clinical Benefit’ Over Time: EMPULSE

Shelley Wood

November 14, 2021

News Opinion Editor's Corner AHA 2021

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

Shelley Wood

November 08, 2021

News Opinion CV Team Dispatch

November 2021 News Roundup

L.A. McKeown

November 01, 2021

Advertisement

The Hunt for Protein Culprits in COVID-19’s Cardiac Complications

Seasonal, but No Year-round Help for HF With Flu Shots: IVVE

What’s Going to Be Hot at ACC 2022, In Person or Virtual

FDA Grants Expanded Indication to CardioMEMS PA Pressure Monitor

Study Touts Benefits of Exercise as Primary CVD Prevention in Older Adults

Reports of Sudden Deaths Among Athletes After COVID-19 Vax Are ‘Misinformation’

Xenotransplant of Pig Heart ‘Just Baby Steps,’ Lead Surgeon Says

February 2022 News Roundup

Realistic Expectations Emerge After Initial Excitement Over Xenotransplant

Cardiac Abnormalities Seen After COVID-19, but Recovery Is Quick

January 2022 News Roundup

World-wise: As In-Person Meetings Resume, Global Voices Hope to Be Heard

Meta-analysis of Pivotal SGLT2 Inhibitor Trials Boosts Hopes in HFpEF

Risk-Based EHR Alert Doesn’t Improve HF Care or Outcomes: REVEAL-HF

Empagliflozin Retains Benefits in ‘True’ HFpEF Patients

Trial of Cell Therapy for HF Misses Primary Endpoint, but Signals a Path Forward

Canagliflozin Improves Quality of Life in HF Patients

Empagliflozin Safe in Acute HF, Improves ‘Clinical Benefit’ Over Time: EMPULSE

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

November 2021 News Roundup

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content